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ttp://dx.doi.org/10.1016/j.ajpath.2012.11.023Endothelial cell (EC) dysfunction is a key feature of multiple organ injury, the primary cause of fatality
seen in critically ill patients. Although the development of EC dysfunction in the heart and lung is well
studied in sepsis, it remains unclear in the liver. Herein, we report that liver sinusoidal ECs (LSECs;
deﬁned as CD146þCD45) exhibit increased intercellular adhesion molecule-1 (CD54) and Fas in
response to sepsis induced by cecal ligation and puncture (CLP). By using magnetically enriched LSEC
(CD146þ) populations, we show evidence of marked apoptosis, with a twofold decline in viable LSECs in
CLP animals compared with sham controls. These changes and increased serum alanine aminotransferase
levels were all mitigated in septic Fas/ and Fas ligand/ animals. Although we previously reported
increased numbers of Fas ligand expressing CD8þ T lymphocytes in the septic liver, CD8þ T-cell deﬁ-
ciency did not reverse the onset of LSEC apoptosis/damage. However, Kupffer cell depletion with
clodronate liposomes resulted in greater apoptosis and Fas expression after CLP and a decrease in
glycoprotein 130 expression on LSECs, suggesting that STAT3 activation may protect these cells from
injury. Our results document a critical role for death receptoremediated LSEC injury and show the ﬁrst
evidence that Kupffer cells are essential to the viability of LSECs, which appears to be mediated through
glycoprotein 130 expression in sepsis. (Am J Pathol 2013, 182: 742e754; http://dx.doi.org/10.1016/
j.ajpath.2012.11.023)Supported by NIH grants F31-DK083873 (N.A.H.), R25-HL088992
(J.N.B.), and R01-GM053209 (A.A.).Sepsis is the leading cause of death in critically ill patients
in intensive care units and arises from the development of
multiple organ injury, for which treatment options are
limited.1,2Our laboratory studiesmurine polymicrobial sepsis
[cecal ligation and puncture (CLP) method] and focuses on
the liver to understand the pathophysiological characteristics
of multiple organ injury. The liver is susceptible to sepsis-
induced inﬂammation because escaping microbial antigens/
mediators arising from the gastrointestinal tract of the septic
animal pass through the liver.
Under normal conditions, the liver is considered to be
immune tolerant (it does not respond to microbial or food
antigens often derived from the portal blood system). Liver
sinusoidal endothelial cells (LSECs), an important special-
ized cell population, contribute to maintaining liver immune
tolerance.3e6 LSECs are the predominant population in the
hepatic sinusoid and form a barrier between the hepatocytesstigative Pathology.
.and blood, which is separated by the space of Disse.4 Kupffer
cells (KCs), the primary resident macrophage population of
the liver, are also situated within the hepatic sinusoid and
strategically sit on top of LSECs.4 LSECs andKCs often act as
the ﬁrst responders during inﬂammation and express classic
pattern recognition receptors, such as toll-like receptor-4,
along with other scavenger receptors.3,4,7 LSECs have a high
endocytotic capacity; they can absorb acetylated low-density
lipoprotein and act as antigen-presenting cells (APCs). They
also express major histocompatibility complex class I and II,
and costimulatory markers, CD80 and CD86.3e5
Importantly, unlike vascular endothelial cells (ECs),
LSECs do not have an organized basement membrane and
are fenestrated.4 These fenestrations allow for an exchange of
KCs and LSECs in Sepsisnutrients in the parenchyma, and cross talk with hepato-
cytes.4 In fact, it has been proposed that the cross talk
between hepatocytes and LSECs in the liver, are physiolog-
ically important for liver homeostasis, organogenesis, and
regeneration.8,9 However, LSECs are difﬁcult to isolate and
study due to controversy in deﬁning these cells.10 LSECs are
also phenotypically different from vascular ECs, as LSECs
are often characterized as CD146þCD45 or CD31þCD45
expressing cells.11e14 Although both KCs, and LSECs
express Fas, it has been proposed that LSECs may undergo
Fas-mediated apoptosis, making the liver, along with the
retina of the eye, one of two characterized organs that has
been shown to undergo Fas-mediated apoptosis.15e17
Our previous studies have shown that there is a twofold
increase in the number of Fas ligand (FasL)eexpressingCD8þT
cells in the liver, 24 hours after CLP, and a signiﬁcant increase in
the number of apoptotic and/or necrotic nonleukocytic cells.
Unfortunately, it still remains unclear as to what cell types are
undergoing apoptosis and how this process is regulated.18,19
The endothelium acts as an initial line of defense against
invading pathogens, and it regulates vascular tone and per-
meability. Therefore, EC dysfunction is a signiﬁcant problem
in sepsis. However, most of what we understand is derived
from nonhepatic vascular beds and cell lines, with few studies
focusing on hepatic endothelium dysfunction in septic mod-
els.20e26 Because injured ECs detach from their basement
membrane, and circulate freely throughout the bloodstream,
there has been great debate as whether endothelial apoptosis
canbedetected in vivoduring sepsis.23,27 In this study,wehave
attempted to determine if LSECs undergo apoptotic cell death
during sepsis and what controls this process and the degree to
which these changes are associatedwith liver injury.We found
that KCs are physiologically relevant to LSEC biological
characteristics and protect LSECs and, indirectly, hepatocytes
from further injury during septic inﬂammation.
Materials and Methods
Animals and Animal Use
All experiments conductedwith animals in this study have been
approved by the animal care use committee (No. 0053-10)
at Rhode Island Hospital, Providence, RI and conform to the
laboratory animal care guidelines set forth by the NIH. Age-
matched (6 to 8 weeks) male mice were ordered from Jackson
Laboratories (Bar Harbor, ME) for C57/BL6 wild-type (BL6),
FasL-deﬁcient (FasL/, Stock number: 1021), Fas deﬁcient
(Fas/, Stock number: 000482), and CD8 deﬁcient animals
(CD8/, Stock Number: 002665).
Cecal Ligation and Puncture
Male mice were anesthetized using isoﬂurane. A 1- to 2-cm
midline incision was made below the diaphragm. The
cecum was exposed, ligated with a sterile silk thread, and
punctured twice with a 22-gauge needle. One punctureThe American Journal of Pathology - ajp.amjpathol.orgoccurred at the site closest to the ligation, whereas the other
puncture was made at a site distal from the ligation. After
puncturing, fecal material was allowed to extrude into the
abdominal cavity. The wound site was numbed with lido-
caine, and the viscera and skin layers were sewn back in
place with a 6.0 nylon silk suture. Sham controls were
exposed to the same surgery; however, their cecum was
neither ligated nor punctured. The animals were resuscitated
with 1.0 mL of lactate ringer’s solution subcutaneously.28
NPC Isolation
Animals were sacriﬁced by CO2 asphyxiation, 24 hours after
CLP/sham. The liver was then perfused with a collagenase IV
(Sigma-Aldrich, St. Louis, MO) buffer [1% collagenase IV
from Clostridium histolyticum and 0.02% DNase I in
10 mmol/L HEPES-NaOH (pH 7.4), 150 mmol/L NaCl,
5 mmol/L KCl, 1 mmol/L MgCl2, and 1.8 mmol/L CaCl2 in
1 PBS]. After perfusion, the liver was excised, minced, and
digested for 30 minutes at 37C. The collagenase was
neutralized by ice-cold 1 PBS, and the hepatocytes were
separated by slow centrifugation at 30  g for 10 minutes.
The supernatants were then spun at 300 g for 10 minutes to
pellet the nonparenchymal cell (NPC) fraction. The pellet
was resuspended in Dulbecco’s modiﬁed Eagle’s medium
complete (10% fetal bovine serum and 500 mg/mL genta-
micin), layered on top of 30% Histodenz (Sigma-Aldrich),
and spun at 1650  g for 25 minutes at 4C; cells at the
interface layer were collected, washed, and counted.11
Staining for LSECs
NPCs were blocked with Fc blocker (CD32/CD16; Bio-
Legend, San Diego, CA), 0.2 mg/mL, for 15 minutes at
4C and stained for extracellular markers, antiemouse
CD45ephosphatidylethanolamine (PE) Cy7 (eBioscience,
San Diego) and antiemouse CD146-PE (BioLegend) or
antiemouse CD31-PE (eBioscience) for 45 minutes at 4C.
Isotype controls were also stained at the same time, as
indicated by each manufacturer. For intercellular adhesion
molecule (ICAM)-1 staining, CD54 (ICAM-1)-allophyco-
cyanin (APC) (BioLegend) was used in combination with
CD45-PE Cy7 and CD146-PE. For Tie2 staining, CD202b
biotin (eBioscience) was combined with CD146-PE and
CD45-PE Cy7 for 30 minutes at room temperature, and then
streptavidin-APC was added for 15 minutes at 4C. For Fas
staining, Fas biotin (eBioscience) was combined with
CD146-PE and CD45-PE Cy7 for 30 minutes at room
temperature, and then streptavidin-APC was added for 15
minutes. For glycoprotein 130 (gp130) staining, gp130-APC
(eBioscience) was combined with CD146-PE and CD45-PE
Cy7 for 45 minutes at 4C. After staining, cells were washed
and then resuspended in staining buffer, and read at 50,000
events on a BD FACSArray (BD Biosciences, San Jose,
CA). Fluorescence-activated cell sorter analyses were
prepared by FlowJo software (Tree Star Inc., Ashland, OR).743
Hutchins et alMagnetic Bead LSEC (CD146þ) Enrichment
The single NPC suspension was isolated and processed as
previously described in NPC isolation section. Liver CD146þ
cells from the NPC population were puriﬁed and separated by
positive-selection magnetic beads.29 Phenotype and purity
were determined by ﬂow cytometry staining with a CD146-
PE antibody and a CD31-PE antibody, and read at 50,000
events on a BD FACSArray.
Annexin V Staining of LSECs
The cells were initially stained as previously described with
extracellular LSEC phenotypic markers for CD146, CD31,
and CD45. After staining for extracellular phenotypic
markers (45 minutes at 4C), the cells were washed and
stained with Annexin VeAPC (BD Biosciences) for 15
minutes at room temperature in 1 Annexin V binding
buffer. Cells were washed again after staining, and read at
50,000 events on a BD FACSArray.
TEM of Enriched LSECs
After magnetic bead enrichment, LSECs were washed,
counted, and spun down.29 The pellets were ﬁxed with 2.5%
glutaraldehyde, washed, and postﬁxed with 1% osmium
tetroxide. After postﬁxation, pellets were rinsed, dehydrated,
inﬁltrated, and embedded in Spur’s epoxy resin. Ultrathin
sections (50 to 60 nm thick) were prepared and retrieved
onto 300 mesh copper grids. Sections were examined using
a Morgagni 268 microscope (FEI Company, Hillsboro, OR),
and images at 7100 magniﬁcation were collected with an
AMT Advantage 542 charge-coupled device camera system.
For the quantiﬁcation of TEM, random ﬁelds were taken at
3500 magniﬁcation from sham and CLP samples. Cells
within each ﬁeld were then characterized into three categories:
apoptotic, normal, and undeterminable status. Apoptotic cells
were classiﬁed by hallmark morphological characteristics to
the nuclei and cytoplasm.30 The percentage apoptotic cells per
total cell number in a given ﬁeld was calculated, and the values
are expressed as means  SEM for 10 ﬁelds per group.
In Situ Staining
Livers were perfused with PBS in situ and excised from C57/
BL6 animals after sham and/or CLP surgery. Representative
tissue sections were then ﬁxed in 10% formalin and
embedded in parafﬁn. Tissue sections (6 mm thick) were cut
and mounted onto glass slides (Paul Monﬁls; Core Research
Laboratories, Rhode Island Hospital, Providence, RI), and set
aside for staining.
For TUNEL staining, rehydrated (xylene, 100%, 95%,
and 70% ethanols, and distilled water) parafﬁn slides
underwent epitope antigen retrieval in citrate buffer (Dako
Agilent Technologies, Carpentaria, CA) for 20 minutes.
After antigen retrieval, slides were permeabilized with 0.1%744Triton X-100 and rinsed with distilled water, and an in situ
cell death mix solution (dilution, 1:100, provided by Roche
Applied Science, Indianapolis, IN) was added for 1 hour at
37C. Slides were then washed in PBS and stained for
CD146, an endothelial marker.
For CD146 (endothelial) staining, slides were washed in
PBS and blocked overnight in 5% goat serum at 4C. After
blocking, slides were then washed again, blocked with avidin
Debiotin (a kit provided by Vector Laboratories, Inc., Bur-
lingame, CA), and stained with anti-CD146 (1:100, ab75769;
Abcam, Inc., Cambridge,MA) overnight at 4C. The next day,
slides were washed again in PBS, and a secondary antibody
(1:1000; anti-rabbit Alexa Fluor 594, provided as a gift from
Dr. Reichner) was added for 1 hour at room temperature.
Slides were then coverslipped and mounted with Vecta-
shield (Vector Laboratories, Inc.), including a DAPI stain.
Imageswere acquiredwith aNikonC1si confocalmicroscope
(Nikon Inc., Melville, NY) using diode lasers 402, 488,
and 561. Serial optical sections were performed with EZ-
C1 computer software (Nikon Inc.). Z-series sections were
collected at 0.25mmwith a 60PlanApo lens and a zoomof 2.
Each wavelength was acquired separately by invoking frame
lambda. Images were processed with Elements computer
software (Nikon Inc.).
Vascular Leakage Assay
At 24 hours after sham and/or CLP surgery was performed,
animalswere i.v. injectedwith0.2mLofEvansBlueDye (EBD;
0.5% w/v; Sigma-Aldrich). After 15 minutes, the animals were
euthanized and the liver tissue was perfused with 1 PBS,
weighed, and extracted in formamide at 37C for 48 hours.
Serum samples were also collected. Extracted tissue samples
were spun down at 500 g, and the supernatants were read on
a spectrophotometer at 610 nm. The tissue EBD concentration
(mg/mL) was determined by the OD readings and compared
with the standard curve. Data are expressed by determining the
OD concentration value of the tissue (mg/mL), normalized to
the OD concentration collected in serum (mg/mL).12
KC Depletion
Clodronate and PBS control liposomes were obtained
from Dr. Nico van Rooijen (Department of Molecular Cell
Biology, Vrije Universiteit, Amsterdam). Clodronate and
PBS liposomes were vortex mixed and diluted 1:5 with 1
PBS, then injected i.v. into C57BL/6 animals. Two days later,
CLP and/or sham surgery was performed, as previously
mentioned.31,32
IL-6 Enzyme-Linked Immunosorbent Assay and ALT
Levels of Mouse Serum
Whole blood samples were collected by cardiac puncture,
using heparinized needles, fromanimals 24hours after surgery,
and spun down at 9300  g for 10 minutes. For IL-6, serumajp.amjpathol.org - The American Journal of Pathology
Figure 1 LSEC phenotyping from sham and CLP BL6 animals. A: Typical
gating strategy for NPCs stained for LSEC markers, using side scatter
versus forward scatter. B: Representative dot plot of CD146þCD45-
expressing cells based on CD45 versus CD146 ﬂuorescence staining
intensity, which consist of approximately 25% to 30% NPCs. C: Repre-
sentative dot plot of CD31þCD45-expressing cells that are approximately
22% to 30% of NPCs. D: There is no difference in Tie2 expression of gated
CD146þCD45 cells between CLP BL6 and sham BL6 animals. E: Tie2
expression of gated CD31þCD45-expressing cells (nZ 3 to 5 per group).
P > 0.05, determined by the Mann-Whitney U-test. Data are expressed as
means  SEM.
KCs and LSECs in Sepsislevels were detected by an antibody-paired kit from BD
Biosciences, and read at an absorbance of 405 nm on a Bio-
Rad Benchmark Plus microplate spectrophotometer (Bio-Rad
Laboratories, Hercules, CA). For alanine aminotransferase
(ALT) levels, serum was detected by a kit (Biotron Diagnos-
tics, Hemet, CA), and read at an absorbance of 540 nm.Normal
ranges forALT are 5 to 30U/L,with the linear limit at 130U/L.
Statistical Analysis
Analyses were conducted by GraphPad Prism version
5 (GraphPad Software, Inc., La Jolla, CA) and graph data
are shown as means  SEM. Signiﬁcant differences were
established between groups when P  0.05, as calculated
based on statistical tests; a Mann-Whitney U-test/rank sum
nonparametric test for two groups; and a nonparametric
one-way analysis of variance to test for the presence of a
signiﬁcant difference for more than two groups, along with
a Holms-Sidak multiple comparisons test to quantify signif-
icant differences between groups.
Results
LSEC Isolation and Phenotyping from Septic and
Nonseptic Animals
We ﬁrst decided to determine the frequency and number of
LSECs in the NPC population through ﬂow cytometry. Our
gating strategy for LSECs was based on published ﬂow cyto-
metric dot-plot approaches (Figure 1, A andB).We gated on the
general NPC population by side scatter versus forward scatter,
followed by delineation of LSECs with the markers, CD31 or
CD146, as previously reported.11e14 Monocytes, granulocytes,
and leukocytes also express CD31; therefore, CD146 (or
melanoma cell adhesion molecule) has been reported as a more
speciﬁc marker for hepatic sinusoidal endothelium.14,33 The
CD146 marker has also been shown to associate with the
endothelial junctions and actin cytoskeleton.33 Because some
resident T cells express CD146, we excluded leukocytes
with CD45 staining (ie, CD146þCD45) Figure 1B). We
observed that there were no differences in percentage between
CD146þCD45 andCD31þCD45 expressing cells in the liver
taken from Sham and CLP animals (Figure 1B and C), and
considered the CD31þCD45 staining as a positive control for
CD146þCD45 expressing cells. These deﬁned LSEC pop-
ulations (CD146þCD45 or CD31þCD45) constitute for
24.39  7.51% (Sham), and 23.91  10.68% (CLP; means 
SD) of the total NPC population (Figure 1B and C). To further
verify that the LSEC populations of interest (by staining for
CD146þCD45 and CD31þCD45) were indeed ECs, we
validated that they expressed an additional endothelial cell
marker, Tie2. Our gated LSEC populations (populations stained
with CD146þCD45 or CD31þCD45) did express Tie2, as
seen with three-color staining (Figure 1, D and E). Ebrahim-
khani et al34 recently also conﬁrmed Tie2 as a marker for
LSECs; this cell population was sorted by a ﬂow cytometerThe American Journal of Pathology - ajp.amjpathol.org 745
Hutchins et alas CD11bTie2þ expressing cells. Herein, because both the
Tie2 expression and CD31þCD45 staining conﬁrmed the
CD146þCD45 staining, in the context of this study,wedeﬁned
our LSEC population as CD146þCD45 expressing cells.
LSECs Are Activated during Sepsis
Previous studies have shown that inﬂammation causes
a direct increase of activation or adhesion molecule expres-
sion, such as ICAM-1 and vascular adhesion molecule-1, on
sinusoidal endothelium in rat CLP models.35 We wanted to
establish whether ex vivo LSECs showed evidence of acti-
vation after the onset of polymicrobial sepsis. We observed
herein that CLP induced a marked increase in ICAM-1
expression on LSECs (gated on CD146þCD45 cells) at
24 hours by three-color staining (Figure 2A). The increased
expression of ICAM-1 on the LSEC population suggests
that the sinusoidal endothelium is activated by direct
interaction of leukocytes during sepsis. In addition, we
observed that the LSECs (gated on CD146þCD45 cells)
exhibited an increase of the Fas death receptor (an
apoptosis signaling molecule) 24 hours following CLP
when compared to sham controls (Figure 2B). We also saw
similar increases of Fas in the CD31þCD45 population
(data not shown). The marked increase of Fas on the LSEC
population is an interesting result, because the Fas receptor
has been reported to be a marker of activation and an
indicator of LSEC apoptosis.15,17Figure 2 The LSEC population is activated after CLP. A: There is an
increase of ICAM-1 (CD54) expression on LSECs (gated on CD146þCD45-
expressing cells) after CLP (nZ 9 per group). B: There is an increase of Fas
expression on LSECs (gated on CD146þCD45-expressing cells) after CLP
(n Z 4 to 6 per group). *P < 0.01 for CLP BL6 versus sham BL6. P values
were determined by a nonparametric Mann-Whitney U-test. All data are
expressed as means  SEM.
746Sepsis Causes an Increase of Liver Tissue Permeability
and Injury in Situ
Because the septic mouse NPCs had an increase of Fas
expression on our deﬁned LSEC population (CD146þCD45
expressing cells), we wanted to determine whether these cells
were undergoing apoptosis during sepsis. However, when we
simply examined the total NPC population for its expression
of the early apoptotic marker, Annexin V, and total cell yield,
we noted a modest declining trend in total NPC number as
opposed to elevated Annexin V in the CLP mice (these
differences were not statistically signiﬁcant) (Figure 3, A and
B). We did notice, however, that there was a signiﬁcant
increase of protein vascular leakage in whole liver tissue, as
assessed by Evans Blue Dye (Figure 3C). This suggests that
the sinusoidal endothelium had an increased permeability,
and was undergoing some form of injury during CLP. We
then decided to examine the sinusoidal endothelium in situ for
indices of injury during sepsis. Herein, we stained sinusoidal
endothelium for CD146 (EC marker) and TUNEL (apoptotic
marker). The CD146 marker, which appears red, lines along
the sinusoidal space and stains ECs (Figure 3D). Both sham
and CLP liver tissue sections had CD146þ ECs within their
sinusoidal spaces (Figure 3, D and E). There were decreased
sinusoidal spaces in the CLP liver sections and decreased ECs
present within these spaces. There was also more TUNEL
staining of the actual ECs present in the CLP liver tissue
(Figure 3E) sections compared with shams (Figure 3D).
Although these qualitative data were encouraging, we de-
cided to isolate the LSECs ex vivo to further clarify the nature
of their developing dysfunction in response to sepsis.
Enriched LSECs Undergo Apoptosis in Sepsis
Concerned that the changes in the LSECs might be diluted in
the whole NPC isolation, we chose to enrich for CD146þ (by
positive magnetic bead selection) from the NPC fraction, and
subsequently stained forAnnexinV.Wedetermined the purity
for our enriched CD146þ cells to be>80% (CD146þCD45)
and 90% (CD31þCD45) (Figure 4A) by ﬂow cytometry. By
staining for Annexin V on gated CD146þCD45 (Figure 4C)
and CD31þCD45 (Figure 4D) populations, we found that
both exhibited a signiﬁcant increase in Annexin V after CLP
compared with sham animals, indicating that LSECs undergo
apoptosis during sepsis. More important, we noted that this
increase in Annexin V staining on the CLPmouse LSECs was
associatedwith amarked decline in the total enrichedCD146þ
cell number when compared with sham (Figure 4B). It should
also be appreciated that the highAnnexinVbaseline staining is
likely attributed to the processing and manipulation of the
liver, which occurs when isolating and enriching for the
LSECs. When we stained naïve BL6 background animals for
Annexin V, we see similar (20% to 30%) Annexin V staining
levels to those of sham controls (Figure 4, C and D). The
CD146þCD45 and CD31þCD45 staining of the enriched
CD146þ cells were comparative in frequencies between shamajp.amjpathol.org - The American Journal of Pathology
Figure 3 There is an increaseof liver tissuepermeability and in situEC injury in sepsis.A: There is nochange inNPCnumbersbetweenshamandCLPBL6animalsbefore
magnetic enrichment.B: There is a10%difference inAnnexinVbetween shamandCLPBL6LSECs (gatedonCD146þCD45-expressing cells) before enrichment (nZ5 to6
per group). C: There ismore albumin protein leakage, as assessed by Evans Blue Dye in liver tissue taken from CLP BL6 versus shamBL6 animals. *P< 0.05 (nZ 4 to 6 per
group), determined by a nonparametric Mann-Whitney t-test. All data are expressed as means SEM. Confocal immunoﬂuorescence representative images of sham (D)
and CLP (E) liver tissue sections. Original magniﬁcation,60. Liver tissue sections were stained with CD146 (red; EC marker), TUNEL (green; apoptosis), and DAPI (blue;
nuclei).D: Gray arrows indicate sinusoidal ECs (red) from sham tissue sections and their nuclei (blue). E:White arrows indicate TUNEL-positive ECs (green and red) from
CLP tissue sections and their nuclei (blue). There is greater TUNEL-positive staining in CLP sinusoidal endothelium compared with sham controls.
KCs and LSECs in Sepsisand CLP; thus, we decided (for the ease of presentation) to
show only the CD146þCD45 (deﬁned as enriched LSECs)
staining in the subsequent ﬁgures (Figures 5, 6, and 7).
Once we had established that the enriched (CD146þ) LSEC
population appears to exhibit early evidence of apoptosis,
shown by increased Annexin V staining, we thought it was
important to evaluate if actual morphological apoptotic
changes existed between enriched LSEC populations from
sham and CLP animals. Our representative TEM images
indicated that there was generally more nuclear fragmenta-
tion, chromatin condensation, and cytoplasmic blebbing in
CLP CD146þ-enriched LSECs compared with sham controls
(Figure 4, E and F). Quantiﬁcation of the TEM data indicated
that the percentage of morphologically apoptotic cells was
increased in LSECs isolated from CLP animals (Figure 4F),
further supporting our earlier Annexin V staining ﬁndings that
imply LSECs exhibit increased apoptosis during sepsis.
Fas-Induced Apoptosis of LSECs during Sepsis
Because we observed an increase in LSEC Fas expression,
we next decided to see if CLP-induced LSEC apoptosis wasThe American Journal of Pathology - ajp.amjpathol.orgaltered in Fas genetically deﬁcient animals. In this set of
experiments, we observed a signiﬁcant decrease in Annexin
Vþ staining in the CLP Fas/ mice (Figure 5A) and an
increase in the total cell numbers after CD146þ enrichment
compared with CLP BL6 mouse cells (Figure 5B). Overall
liver injury, as assessed by ALT levels, also decreased in the
CLP Fas/ animals compared with CLP BL6 mice
(Figure 5C). These data demonstrate that LSEC apoptosis is
mediated by Fas ligation.
To further support our observations, we subsequently
examined Annexin V staining of CD146þ-enriched LSECs
after CLP in BL6 and FasL/ animals. Herein (Figure 6A),
although we observed a marked increase in Annexin V on
CD146þ-enriched LSECs of CLP BL6 compared with sham,
no such increase was seen of Annexin V staining onCD146þ-
enriched LSECs of CLP FasL/ animals compared with
sham FasL/ cells. However, not statistically different from
either sham or CLP BL6Annexin V staining levels, the FasL-
deﬁcient LSECs were not affected (ie, not increased in
Annexin V staining) by CLP in the same manner as the CLP
BL6 mice. Further support for this observation can be seen in
the changes in cell numbers between the enriched CD146þ747
Figure 4 Enriched LSECs exhibit increased apoptosis during sepsis. A: Representative dot plots taken from sham CD146þ-enriched LSECs stained with
CD146þCD45 or CD31þCD45 to indicate isolation purity. B: CD146þ-enriched LSEC number decreases in CLP compared with sham (n Z 4 to 6 per group).
C and D: Annexin Vþ increases in CLP CD146þ-enriched LSECs stained for CD146þCD45 and CD31þCD45 versus sham controls (nZ 5 to 6 per group). Dashed
line represents naïve Annexin V baseline level. E: TEM representative images of CD146þ-enriched LSECs from CLP versus sham BL6 animals. Original
magniﬁcation, 7100. There are more nuclei with condensed chromatin in crescent formation and cytoplasmic blebbing (arrows) in CLP CD146þ-enriched
LSECs, compared with sham. F: Quantiﬁcation of apoptotic enriched LSECs from sham (left panel) and CLP (right panel) animals. Random ﬁelds were scored
and considered to be apoptotic if they had classic morphological changes to nuclei and cytoplasm. Original magniﬁcation, 3500. The percentage of apoptotic
cells per total number of cells in a given ﬁeld was determined (n Z 10 per group). *P < 0.05. P values were determined by a nonparametric Mann-Whitney
U-test. All data are expressed as means  SEM.
Hutchins et alLSECs themselves, because the number of LSECs in BL6
animals decreased substantially after CLP (Figure 6B),
compared with equivalent background sham BL6 controls.
However, the cell numbers of CD146þ-enriched LSECs from
CLP FasL/ animals were similar to sham controls of
FasL/ animals and BL6 mice (Figure 6B). Although
apoptosis of enriched CD146þLSECswas unaffected in CLP
FasL/ animals, we also wanted to assess if liver tissue
injury was affected by measuring ALT enzyme levels. ALT
levels decreased in CLP FasL/ compared with CLP BL6
animals, which, again, implied that FasL gene deﬁciency
plays an indirect role in LSEC injury and/or apoptosis, and has
a global effect on liver tissue parenchymal injury. The
Annexin V staining levels on CD146þ-enriched LSECs from
sham and CLP Fas/ and FasL/ animals were fairly
similar. Collectively, these data suggest that direct forms of
LSEC injury occur because of Fas gene deﬁciency compared748with FasL deﬁciency, which might be mediated through
various FasL effector cells.
CD8þ T Cells Do Not Appear to be Sufﬁcient to
Instigate Fas-Mediated LSEC Apoptosis during Sepsis
Because we had previously reported an increase in the
number of liver CD8þ cells expressing increased levels of
FasL in response to CLP, we attempted to determine whether
the LSEC apoptotic changes are instigated byCD8þT cells.18
We compared CD146þ-enriched LSECs for Annexin V in
CD8/ and BL6 animals. Herein, we noticed that, although
there was a declining trend in Annexin V staining in CLP
CD8/ compared with CLP BL6 animals, it was not statis-
tically signiﬁcant between the CLP and sham CD8/ groups
(Figure 7A). However, the Annexin V staining on CD146þ-
enriched LSECs from CLP CD8/ animals did trend towardajp.amjpathol.org - The American Journal of Pathology
Figure 5 Enriched LSEC apoptosis is Fas dependent. A: Annexin V staining decreased in CD146þ-enriched LSECs from CLP Fas/ animals versus CLP BL6
animals (nZ 4 to 6 per group). Dashed line represents naïve Annexin V baseline level. B: There is a decrease in CD146þ-enriched LSEC number after CLP versus
sham controls. Cell numbers are restored to higher levels in the CLP Fas/ animals after enrichment versus CLP BL6 animals (nZ 6 to 8 per group). C: ALT
levels decreased in CLP Fas/ animals versus CLP BL6 animals (nZ 5 to 9 per group). ALT levels increased in CLP BL6 animals versus sham. *P < 0.05 for CLP
BL6 versus sham BL6; yP < 0.05 for CLP Fas/ versus CLP BL6. P values were determined by a nonparametric one-way analysis of variance test. Data are
expressed as means  SEM.
KCs and LSECs in Sepsisan increase comparedwith shamCD8/ controls.We further
observed that the actual cell yields of CD146þ-enriched
LSECs in the CLP CD8/ animals did not improve to the
same extent as seen in the CLP Fas and FasL/ animals
(Figure 7B), suggesting that CD8þ T cell by LSEC interac-
tions alone are not sufﬁcient to account for modulating Fas-
FasLemediated LSEC apoptosis during sepsis. Similarly,
with the observed lack of signiﬁcant difference between CLP
CD8/ and CLP BL6 LSEC Annexin V staining, there was
also no change in ALT levels between CLPCD8/ and CLP
BL6 (Figure 7C). These observations further validated our
earlier conclusion that CD8þT cells alone play aminor role in
LSEC injury and/or cell death and, perhaps, require the
combined effects of inﬂammation, along with the actions of
other neighboring leukocytes, to mediate their effects on
LSECs and overall liver tissue injury (Figure 7C).
KCs Protect LSECs from Sepsis-Induced Injury
Oncewe determined that CD8þT cells were not the only cells
contributing to LSEC injury, as originally thought (Figure 7),
we decided to determine what role other neighboringFigure 6 Enriched LSEC apoptosis decreases in FasL-deﬁcient animals. A: Ann
LSECs versus CLP BL6 LSECs; however, the P value was not signiﬁcant (n Z 4
B: Enriched LSEC numbers decrease in CLP BL6 animals versus sham controls, and a
C: ALT levels increased in CLP BL6 animals versus sham controls, and the ALT level
group). *P < 0.05 for CLP BL6 versus sham BL6; yP < 0.05 for CLP FasL/ versus
a nonparametric one-way analysis of variance test.
The American Journal of Pathology - ajp.amjpathol.orgleukocytes play in the induction of LSEC apoptosis during
sepsis. KCs are anatomically situated close to LSECs. It has
been previously reported that KCs and LSECs recognize
lipopolysaccharide (LPS) and secrete IL-6 during endotoxin-
induced infections.36,37 Because KCs are physiologically
relevant to LSEC biological features within the hepatic
sinusoid, we sought to determine what role they play in Fas-
mediated apoptosis of LSEC during sepsis.
We depleted KCs (F4/80þ, resident macrophage popula-
tions) by injecting clodronate liposomes i.v., 2 days before
surgery. By the third day, the blood monocytes/macrophages
have had time to reconstitute, whereas the KCs still had not
differentiated.31,32 We conﬁrmed that we had substantially
reduced F4/80þCD11b stained cells in the NPC populations
taken from sham andCLPBL6-clodronateetreated animals by
ﬂow cytometry (Figure 8A). KCs usually comprise approxi-
mately 15% to 20% of the total NPC fraction; however, with
clodronate liposomal treatment, this NPC F4/80þCD11b
population decreased to<5% (Figure 8A).We did not observe
signiﬁcant differences between the sham and CLP PBS control
liposome-injected animals, indicating that the liposomes
themselves did not affect the overall percentage of liver KCsexin V staining trends toward a decrease in CD146þ-enriched CLP FasL/
to 6 per group). Dashed line represents naïve Annexin V baseline level.
re restored back to sham BL6 in CLP FasL/ animals (nZ 6 to 8 per group).
s decreased in CLP FasL/ animals versus CLP BL6 animals (nZ 5 to 9 per
CLP BL6. Data are expressed as means  SEM. P values were determined by
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Figure 7 CD8þ T cells play a minor role in instigating apoptosis of enriched LSECs. A: There is a decrease of Annexin V in CD146þ-enriched LSECs from CLP
BL6 animals versus sham; however, there is no change in Annexin V staining between CLP CD8/ versus CLP BL6 (n Z 6 to 8 per group). Dashed line
represents naïve Annexin V baseline level. B: There is a decrease in the overall cell number of enriched CD146þ LSECs in CLP BL6 versus sham controls. C: Serum
ALT levels increased in CLP BL6 versus sham controls; however, there is no change between CLP CD8/ and CLP BL6 animals (nZ 5 to 9 per group). P value is
for CLP BL6 versus sham BL6. P values were determined by a nonparametric one-way analysis of variance test. Data are expressed as means  SEM. *P < 0.05.
Hutchins et al(F4/80þCD11b population), which remained at approxi-
mately10% (Figure 8A).
On establishing that we could deplete KCs in the liver, we
then conﬁrmed that liposomal treatment did not have adverse
effects on the isolation purity of enriched LSECs (Figure 8B).
We then stained CD146þ-enriched LSECs from CLP-
clodronateetreated and CLP PBS control animals with
Annexin V. We observed that there was a signiﬁcant increase
of Annexin V staining on CD146þ-enriched LSECs from
CLP-clodronateetreated animals, compared with CLP PBS
control animals (Figure 9A). There was also a decline in
the overall CD146þ-enriched LSEC numbers from CLP-
clodronateetreated animals, compared with CLP PBS con-
trol mice, indicating that, in the absence of KCs, LSECs were
more prone to apoptosis (Figure 9B).
KCs express Fas, and on activation with endotoxin, they
have also been reported to up-regulate FasL.17 We wanted








750absence of KCs. Thus, we decided to determine whether the
Annexin V staining and/or apoptotic effects of enriched
CD146þ LSECs from CLP-clodronateetreated animals was
due to Fas expression. We stained enriched CD146þ LSECs
for Fas from CLP-clodronateetreated and CLP PBS control
animals and did not see signiﬁcant changes in Fas expres-
sion between CLP-clodronateetreated and CLP PBS control
cells (Figure 9D). However, we did notice that CD146þ-
enriched LSECs had a greater expression of ICAM-1 in
CLP-clodronateetreated animals compared with CLP PBS
controls (Figure 9C). Because there is a direct loss of KCs
by clodronate, inﬁltrating inﬂammatory monocytes and
neutrophils overcompensate for their loss, and have
increased interactions with the sinusoidal endothelium.
Collectively, these data suggests that, in the absence of KCs,
LSECs still demonstrate increased Fas expression during
sepsis and are subjected to Fas-stimulated apoptosis and
injury.Conﬁrmation of KC depletion in sham and CLP animals. A: Representative
of NPCs taken from naïve untreated, sham, and CLP animals that were
ith either PBS control or clodronate liposomes. Sham and CLP-clo-
eated NPCs were taken from the unenriched fractions, and stained for F4/80
. F4/80þCD11b (KC) cells account for 15% to 20% of the total NPC pop-
d decrease to <5% with clodronate treatment. B: Representative dot plot of
riched LSECs from sham and CLP-clodronateetreated animals; purity is
by liposomes.
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Figure 9 KCs protect enriched LSECs from sepsis-induced injury through gp130 expression.A: There is increased Annexin V staining in CD146þ-enriched LSECs
from CLP-clodronateetreated animals versus CLP PBS controls (nZ 3 to 6 per group).Dashed line represents naive Annexin V baseline level.B: There is a decrease
in the number of CD146þ-enriched LSECs from CLP-clodronateetreated animals compared with CLP PBS controls (nZ 6 to 7 per group). C: There is an increase of
ICAM-1 expression on CD146þ-enriched LSECs from CLP-clodronateetreated animals versus CLP PBS controls, and sham-clodronateetreated animals (nZ 3 to 5
per group).D: There is no change in Fas expression between CD146þ-enriched LSECs fromCLP-clodronateetreated animals versus CLP PBS control animals (nZ 3 to
5 per group). E: gp130 Expression signiﬁcantly decreases on CD146þ-enriched LSECs from CLP-clodronateetreated animals comparedwith CLP PBS controls (nZ 3
to 6 per group). F: IL-6 cytokine serum levels decrease in CLP-clodronateetreated animals compared with CLP PBS controls (nZ 6 to 11 per group).G: ALT enzyme
levels increase in CLP-clodronateetreated animals compared with CLP PBS controls (nZ 6 to 11 per group). *P< 0.05 for CLP PBS versus sham PBS; yP< 0.05 for
CLP-clodronateetreated animals versus CLP PBS controls; and zP< 0.05 for CLP-clodronate versus sham-clodronateetreated mice. P values were determined by
a nonparametric one-way analysis of variance test, followed by a Holms-Sidak multiple comparisons test. All data are expressed as means  SEM.
KCs and LSECs in SepsisIL-6 is a multifunctional cytokine and one of the acute-
phase proteins that are predominately produced in the liver.8
Although KCs and hepatocytes are the main producers of IL-
6 in the liver, IL-6 secretion is also heavily regulated by the
IL-6 receptor or gp130.7 We wanted to determine whether
CD146þ-enriched LSECs from clodronate-treated animals
still had the ability to respond to IL-6. We stained CD146þ-
enriched LSECs for gp130. Interestingly, we found that
CD146þ-enriched LSECs from CLP-clodronateetreated an-
imals had decreased gp130 (IL-6 receptor b) (Figure 9E). As
a result, these CD146þ-enriched LSECs from CLP-clo-
dronateetreated animals were less protected from apoptosis
and overall liver tissue injury (increasedALT enzyme levels in
CLP-clodronateetreated animals compared with CLP PBS
controls) (Figure 9G). The decrease in gp130 expression of
enriched CD146þ cells correlates to the systemic IL-6 cyto-
kine levels in CLP-clodronateetreated animals (Figure 9F). In
the absence of KCs, the secretion of IL-6 into the blood
decreases, further suggesting that KCs alone help to protect
LSECs from septic-induced injury.Discussion
The liver is a critical organ that regulates host metabolism
and blood detoxiﬁcation and maintains a functional immuneThe American Journal of Pathology - ajp.amjpathol.orgresponse to exogenous infectious challenge. The liver also
frequently becomes dysfunctional in response to insults,
such as shock-associated injury and/or sepsis. These injuries
contribute to the morbidity associated with multiple organ
failure seen in critically ill patients.8,38 However, although
signiﬁcant strides have been made to understand the func-
tion and contribution of liver macrophages and/or hepato-
cytes in the pathophysiological changes leading to liver
dysfunction during sepsis, few studies have investigated
ex vivo LSEC function.24e26 It has been well established
that ECs play a role in the inﬂammatory response; however,
most of this knowledge is based on work done with ECs in
vascular beds outside the liver.21,23 The inability to readily
isolate and characterize LSECs, and to assess their response
ex vivo to infectious sepsis-associated stimuli, made them
a more challenging cell population to investigate.10 The goal
of this study was to determine whether hepatic endothelial
activation and damage contributes to liver injury seen in
septic animals and how this might be regulated. We found
that LSECs undergo Fas-mediated apoptosis during sepsis
and are protected by KCs through their gp130 expression.
We initially hypothesized that inﬁltrating FasL-
expressing CD8þ T cells instigate apoptosis of neigh-
boring LSECs through the engagement of their Fas receptor.
This was based on our previous ﬁnding that there was
a twofold increase of FasL-expressing liver CD8þ T cells751
Hutchins et alafter sepsis.18 To test this concept, we ﬁrst phenotypically
deﬁned LSEC populations (CD146þCD45), as shown in
Figure 1B, and conﬁrmed that the actual LSEC population
was of an endothelial lineage, with CD31 and Tie2
expression (Figure 1, C and D). We then determined that
they underwent apoptosis in response to septic challenge in
situ and ex vivo (Figures 3D, 3E, and 4C). We also exam-
ined whether CD8þ T cells inﬂuence the development of
LSEC injury and apoptosis. Our results from this study
indicate that LSEC dysfunction (as it relates to activation,
injury, and apoptosis) does occur in the hepatic sinusoid
during sepsis (increases in ICAM-1, Fas, and Annexin V)
(Figures 2 and 4). However, the process is mainly dependent
on Fas expression of LSECs (Figures 5 and 6) and regulated
by KCs (Figure 9). CD8þ T cells, however, play a minor
role (Figure 7), whereas KCs help to decrease the associated
detrimental effects of sepsis and Fas-induced injury on
LSECs by secreting IL-6 and engaging gp130 (Figure 9).
Instead of pinpointing the CD8þ T cells as a culprit for
Fas-mediated LSEC cell death, we should consider that
CD8þ T cells actually prime the EC, and enhance Fas-
induced effects. Their interaction with LSECs remains
unique; LSECs act as APCs and initially prime CD8þ T cells
outside of the context of inﬂammation.6 Kennedy et al39 have
shown that antigen-induced liver damage by inﬁltrating
CD8þ T cells can be mediated in an Fas-dependent manner.
Because we did not see stark changes in Annexin V staining
of LSECs between CLP BL6 and CLP CD8/ animals
(Figure 6A), we believe that FasL on CD8þ T cells alone is
not sufﬁcient to instigate Fas-mediated LSEC sepsis-induced
apoptosis.
We believe that there are more direct effects in Fas/
animals compared with FasL/ animals. This may be
because FasLþ-expressing leukocytes may not be the only
cells that come in contact with the sinusoidal endothelium,
and cause direct damage. There are other methods of
endothelial cell apoptosis; one hallmark study has indicated
that IL-6 and tumor necrosis factor-a are responsible for
hepatocellular dysfunction seen in sepsis.26 The combined
inﬂammatory milieu (ie, cytokines, such as tumor necrosis
factor-a and bacteria) induced by polymicrobial septic
insult, together with LSEC’s Fas expression, contributes to
their demise. This might explain why there was no signiﬁ-
cant difference of Annexin V staining in enriched LSECs
from CLP FasL/ animals compared with CLP BL6
animals (Figure 6A). Yet, we saw differences in overall liver
injury and cell yields (Figure 6, B and C) because the Fas
receptor is still present.
In our model, once LSECs become activated, as indicated
with an increased expression of ICAM-1 and Fas (Figure 2)
during sepsis, we speculate that they should no longer be
able to sustain a state of hepatic immune tolerance. Our
results are promising because they coincide with a recent
report that ICAM-1 is required to allow cross presentation of
antigen to CD8þ T cells.34 In addition, adhesion molecule
expression has been shown to directly correlate with the752transmigration and extravasation of leukocytes into the
hepatic sinusoid in an LPS model of sepsis.40 Our data,
however, extends the story that perhaps CD8þ T cells
activate LSECs, but do not directly induce apoptosis. In
fact, increases in endothelial ICAM-1 could indicate that
both FasLþ- and noneFasLþ-expressing leukocytes are able
to potentiate sinusoidal EC injury, and this could also
explain why we do not see stark differences in FasL/
animals (Figure 6). However, on further activation and
prolonged contact with inﬁltrating leukocytes and bacterial
products, LSECs eventually become injured and then ulti-
mately undergo apoptosis (increases of Annexin V and
TUNEL staining), culminating in a decrease in overall cell
number and increases in tissue permeability (Figures 3 and
4) and ALT (Figure 5). Overall, the harmful Fas-induced
effects of LSEC injury in sepsis are regulated by the
ability of KC to secrete IL-6 and signal to LSECs (Figure 9).
We believe that our ﬁndings from this study are novel
because few have considered the role KCs play in the cross
talk between LSECs and hepatocytes during injury. Other
models have, however, shown that KCs are protective during
septic peritonitis. When KCs were depleted with clodronate
liposomes in septic peritonitis, mice exhibited decreased
survival, and their mortality was shown to be due to the
inability of KCs to produce pro-inﬂammatory cytokines.36
Actually, KCs might be the link that provides the indirect
protection of hepatocytes from further Fas-induced injury by
secreting IL-6, binding to gp130 on LSECs, and indirectly
activating STAT3. It has been reported that STAT3 plays
a major role in liver development and regeneration by pro-
tecting hepatocytes from Fas-induced liver injury.41,42
Our data show that KCs are needed within the hepatic
sinusoid to protect LSECs from further injury (Figure 9). We
believe that this phenomenon occurs because, in the absence
of KCs, inﬂammatory monocytes and/or neutrophils over-
compensate for their loss and exacerbate injury of the sinu-
soidal endothelium. Normally, there aren’t many neutrophils
in the liver; however, sepsis inﬂuences their inﬁltration, as
seen in an LPS model of shock.43 We noted an increase of
CD11bþ or immaturemonocyte/granulocyte populations after
CLP (Figure 8A), again suggesting that neutrophils (or some
other granulocyte populations) may directly injure ECs during
septic inﬂammation. As a result of greater neutrophil inﬂux
into the liver without KCs present, this culminates in higher
levels of serum ALT, Annexin V staining on LSEC pop-
ulations, andmore LSECs lost (Figure 9).We also believe that
this correlates with an increase in ICAM-1 staining on LSECs
in the presence of clodronate (Figure 9). Because more
CD11bþ cells are interacting with the sinusoidal endothelium,
a direct correlation exists with CD54 and/or ICAM-1 expres-
sion. Our observation also agrees with a study performed in an
ischemia-reperfusion model, demonstrating that, in the pres-
ence of clodronate, ECs hadmore LPSbinding and an increase
in ICAM-1.44
Surprisingly, we also found that KCs protect LSECs by
secreting IL-6 (there is greater IL-6 cytokine serumajp.amjpathol.org - The American Journal of Pathology
KCs and LSECs in Sepsisproduction from CLP PBS versus CLP-clodronateetreated
animals) (Figure 9F). This was also evident by the drastic
decrease in gp130 on enriched CD146þ LSECs from CLP-
clodronateetreated animals compared with CLP PBS
controls (Figure 9E). The decreased gp130 on enriched
LSECs from clodronate-treated animals possibly suggests
that gp130 promotes cell survival because these cells would
possibly have less STAT3 activation and, therefore, more
apoptosis. STAT3 phosphorylation has been shown to
protect ECs from cell death.45 IL-6 from KCs, a pro-
inﬂammatory cytokine, in this case, is beneﬁcial, because
it will signal to gp130 on LSECs. These data also correlate
with other liver injury models, such as ischemia-reperfusion
and cholestatic injuries, in which KCs also play a protective
role.44,46 It has also been shown in a Gram-positive sepsis
model, when hepatocyte-speciﬁc gp130/ mice were
injected with Streptococcus pyrogenes, there was less IL-6
secretion and KC/neutrophil accumulation in the liver.47
This again implies that the gp130 receptor is involved in
regulating septic inﬂammation, and it proposes that KCs are
possibly needed to modulate potentially harmful neutrophil-
endothelium interactions in the liver.47 KCs and LSECs act
harmoniously together to combat bacterial infections and
clear pathogenic responses. In their absence, there is no
longer a buffer to absorb apoptotic debris, and respond to
danger signals (eg, LPS, bacteria, and endotoxin) that septic
inﬂammation produces. Because we propose that KCs
protect LSECs and, ultimately, hepatocytes from further
injury, in the context of the liver, therapies that target and
modulate KCs should be considered.
In conclusion, apoptosis, in general, has been widely
investigated in septic animal models primarily in immune cell
compartments, but there are limited studies that have focused
on nonimmune cells, such as ex vivo studies performed on
LSECs herein.48 Apoptosis has been shown to play a signif-
icant role in the mortality of critically ill patients, and animal
models of septic injury.48,49 There is consensus that the
mortality seen in critically ill patients is due to an impaired
immune response that results, in part, from apoptosis of
effector immune cells.50 Researchers have shown that anti-
apoptotic molecules, such as anti-caspase 8, anti-caspase 3,
anti-Fas (siRNA against Fas), and antieFasL-blocking
protein, can reduce the mortality associated with sepsis in
animal models.48,51e53 More important, we show that these
same molecules also appear beneﬁcial in reducing LSEC
injury because this study indicates that LSECs also undergo
death receptoremediated apoptosis, as shown with increased
Fas expression (Figures 2B and 9) and Annexin V staining
(Figure 4). Therefore, if LSEC injury is prevented and KCs
remain intact, the parenchyma should be preserved and liver
tissue will continue to function.
Unlike classic in vitro studies that investigate the interac-
tions between leukocytes and vascular ECs outside their
natural tissue microenvironment, we have conﬁrmed that
stressors related to septic challenge uniquely affect recently
extracted LSECs ex vivo. Future studies should investigateThe American Journal of Pathology - ajp.amjpathol.orgthe impact of vascular EC apoptosis and note how this
compares with apoptosis of other tissue-speciﬁc ECs (eg,
kidney ECs, which, like LSECs, are fenestrated) in septic
animal models. Vascular injury in each tissue bed mim-
ics their respective inﬂammatory microenvironments and
directly correlates to organ injury in critically ill patients.Acknowledgments
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